Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic. (2023)

First Author: Kennedy NA
Attributed to:  COVID-19: Data and Connectivity – National Core Study (D&C-NCS) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/gutjnl-2022-327570

PubMed Identifier: 35902214

Publication URI: http://europepmc.org/abstract/MED/35902214

Type: Journal Article/Review

Volume: 72

Parent Publication: Gut

Issue: 2

ISSN: 0017-5749